Radiation-Protective Agents
"Radiation-Protective Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other, e.g. military, purposes.
| Descriptor ID |
D011837
|
| MeSH Number(s) |
D27.505.696.706.776 D27.720.799.763
|
| Concept/Terms |
Radiation-Protective Agents- Radiation-Protective Agents
- Radiation Protectants
- Protectants, Radiation
- Radioprotective Drugs
- Drugs, Radioprotective
- Radiation-Protective Drugs
- Drugs, Radiation-Protective
- Radiation Protective Drugs
- Radioprotective Agents
- Agents, Radioprotective
- Agents, Radiation-Protective
- Agents, Radiation Protective
- Radiation Protective Agents
- Protective Agents, Radiation
Radiation-Protective Effect- Radiation-Protective Effect
- Effect, Radiation-Protective
- Radiation Protective Effect
- Radiation-Protective Effects
- Effects, Radiation-Protective
- Radiation Protective Effects
|
Below are MeSH descriptors whose meaning is more general than "Radiation-Protective Agents".
Below are MeSH descriptors whose meaning is more specific than "Radiation-Protective Agents".
This graph shows the total number of publications written about "Radiation-Protective Agents" by people in this website by year, and whether "Radiation-Protective Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiation-Protective Agents" by people in Profiles.
-
Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Meyskens FL, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 2019 01 01; 125(1):18-44.
-
Saha S, Bhanja P, Liu L, Alfieri AA, Yu D, Kandimalla ER, Agrawal S, Guha C. TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome. PLoS One. 2012; 7(1):e29357.
-
Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A, von Hoff D, Schuchter LM. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol. 2009 Jan 01; 27(1):127-45.
-
Tawar U, Bansal S, Shrimal S, Singh M, Tandon V. Nuclear condensation and free radical scavenging: a dual mechanism of bisbenzimidazoles to modulate radiation damage to DNA. Mol Cell Biochem. 2007 Nov; 305(1-2):221-33.